Legend Financial Statements From 2010 to 2024

LEGN Stock  USD 42.61  1.81  4.44%   
Legend Biotech financial statements provide useful quarterly and yearly information to potential Legend Biotech Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Legend Biotech financial statements helps investors assess Legend Biotech's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Legend Biotech's valuation are summarized below:
Legend Biotech Corp does not presently have any fundamental ratios for analysis.
Check Legend Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Legend Biotech's main balance sheet or income statement drivers, such as , as well as many indicators such as . Legend financial statements analysis is a perfect complement when working with Legend Biotech Valuation or Volatility modules.
Check out the analysis of Legend Biotech Correlation against competitors.

Legend Biotech Corp Company Return On Asset Analysis

Legend Biotech's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset


Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Legend Biotech Return On Asset

Most of Legend Biotech's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Legend Biotech Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.

Based on the latest financial disclosure, Legend Biotech Corp has a Return On Asset of -0.1825. This is 97.91% lower than that of the Biotechnology sector and 99.23% lower than that of the Health Care industry. The return on asset for all United States stocks is 30.36% higher than that of the company.

Legend Biotech Corp Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Legend Biotech's current stock value. Our valuation model uses many indicators to compare Legend Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Legend Biotech competition to find correlations between indicators driving Legend Biotech's intrinsic value. More Info.
Legend Biotech Corp is rated below average in return on equity category among its peers. It is rated fifth overall in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Legend Biotech's earnings, one of the primary drivers of an investment's value.

About Legend Biotech Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Legend Biotech income statement, its balance sheet, and the statement of cash flows. Legend Biotech investors use historical funamental indicators, such as Legend Biotech's revenue or net income, to determine how well the company is positioned to perform in the future. Although Legend Biotech investors may use each financial statement separately, they are all related. The changes in Legend Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Legend Biotech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Legend Biotech Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Legend Biotech. Please read more on our technical analysis and fundamental analysis pages.
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation. Legend Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1071 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Additional Information and Resources on Investing in Legend Stock

When determining whether Legend Biotech Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Legend Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Legend Biotech Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Legend Biotech Corp Stock:
Check out the analysis of Legend Biotech Correlation against competitors.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend Biotech. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Legend Biotech Corp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend Biotech's value that differs from its market value or its book value, called intrinsic value, which is Legend Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend Biotech's market value can be influenced by many factors that don't directly affect Legend Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.